In this edition:
Risk factors for major cardiovascular events in inflammatory arthritis
Safety of JAK vs TNF inhibitors in RA
Long COVID in autoimmune and rheumatic diseases
Low-dose IL-2 treatment for SLE
Risk of autoimmune diseases in patients with COVID-19
Important goals of treatment from AS and PsA patients’ perspectives
COVID-19 in RA patients receiving baricitinib
COVID-19 in pregnant patients with AS
Socioeconomic profile of patients with AS
Social media use among spondyloarthritis experts
Please login below to download this issue (PDF)